This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: NICE guidelines

November 2017 Br J Cardiol 2017;24:129

NICE publishes updated familial hypercholesterolaemia guidance

BJC Staff

Abstract

While most of the recommendations in the new guideline remain unchanged, there are some key updates including the use of the new lipid modifying drugs- PCSK9 inhibitors (for which NICE technology appraisal guidance exists), treatment of children and recommendations to search medical records for those who may be at risk. The guideline also recommends that those at risk of FH should be offered DNA tests to confirm they have the condition. Previously, low-density lipoprotein cholesterol (LDL-C) levels have been used but they are not always accurate. At the moment only 15% of the estimated 260,000 people in the UK with FH have been diagnosed, inc

| Full text
Introduction

November 2016 Br J Cardiol 2016;23(suppl 2):S1–S12 doi:10.5837/bjc.2016.s02

Introduction

BJCardio Staff

Abstract

Drug therapies include anticoagulants to reduce the risk of stroke and anti-arrhythmics to restore/maintain the normal heart rhythm or slow the heart rate in patients who remain in AF. Non-pharmacological management options include electrical cardioversion, which may be used to ‘shock’ the heart back to its normal rhythm. The high risk of stroke associated with electrical cardioversion can be reduced by oral anticoagulation. Although effective in reducing the risk of thromboembolism, the limitations of warfarin present considerable challenges for its use in clinical practice. The challenges of maintaining warfarin within an appropriate th

| Full text
Direct current cardioversion and thromboprophylaxis in atrial fibrillation

November 2016 Br J Cardiol 2016;23(suppl 2):S1–S12 doi:10.5837/bjc.2016.s02

Direct current cardioversion and thromboprophylaxis in atrial fibrillation

BJCardio Staff

Abstract

Understanding the mechanisms of AF lies at the heart of its treatment. AF occurs when structural and/or electrophysiological abnormalities alter atrial tissue to promote abnormal impulse formation and/or propagation (figure 1).3 Multiple clinical risk factors, electrocardiographic/echocardiographic features and biochemical markers are associated with an increased risk of AF (table 1), and, AF can be described in terms of the duration of episodes using a simplified scheme (table 2).3 Figure 1. Mechanisms of atrial fibrillation Table 1. Risk factors3 The aim of treatment is to prevent stroke and alleviate symptoms.4 Drug therapies include antic

| Full text

March 2016 Br J Cardiol 2016;23:37 doi:10.5837/bjc.2016.011

The clinical and cost impact of implementing NICE guidance on chest pain of recent onset in a DGH

Boyang Liu, Regina Mammen, Waleed Arshad, Paivi Kylli, Arvinder S Kurbaan, Han B Xiao

Abstract

Introduction There are 2.3 million people living with coronary heart disease in the UK, which results in a healthcare burden of 1% of all GP and 40% of all accident and emergency (A&E) visits.1 It is estimated that 20–40% of the general population will experience chest pain during their life. Chest pain caused by coronary artery disease has a potentially poor prognosis, emphasising the importance of prompt and accurate diagnosis. Treatments are available to improve symptoms and prolong life, hence, the need for the development of the National Institute for Health and Care Excellence (NICE) guidelines for the diagnosis of chest pain.1 NI

| Full text

March 2012 Br J Cardiol 2012;19:15

Correspondence: Chest pain

Drs Rebecca Cooper, Emma Eade and Andrew RJ Mitchell

Abstract

Do the NICE guidelines for chest pain add up? Dear Sirs, The recent articles by Purvis and Hughes1 and Kelly et al.2 question the issued guidance from the National Institute of Health and Clinical Excellence (NICE) on the investigation of patients with recent onset chest pain.3 Purvis and Hughes focused on the investigation of patients in the low risk category for coronary artery disease (CAD), who under the NICE guidelines would be referred directly for computed tomography (CT) calcium scores (CTC) rather than exercise tolerance tests (ETTs), as is current practice in many hospitals. Their results were inconclusive, indicating that there may

| Full text
Implementation of the new NICE guidelines for stable chest pain: likely impact on chest pain services in the UK

August 2011 Br J Cardiol 2011;18:185–88

Implementation of the new NICE guidelines for stable chest pain: likely impact on chest pain services in the UK

Dominic Kelly, Stephen Cole, Fiona Rossiter, Karen Mallinson, Anita Smith, Iain Simpson

Abstract

(more…)

| Full text

January 2007 Br J Cardiol 2007;14:23-30

The NICE guidelines on atrial fibrillation: a personal view

David Fitzmaurice

Abstract

No content available

| Full text

May 2006 Br J Cardiol 2006;13:169

News

BJCardio editorial team

Abstract

No content available

| Full text

May 2006 Br J Cardiol 2006;13:216-8

The accuracy of ECG screening by GPs and by machine interpretation in selecting suspected heart failure patients for echocardiography

Sanjay Jeyaseelan, Allan D Struthers, Barclay M Goudie, Stuart D Pringle, Frank M Sullivan, Peter T Donnan

Abstract

No content available

| Full text

July 2005 Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 45–AIC 48

Drug-eluting stents: NICE guidelines and the reality

Tim Wells, Keith Dawkins

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now